Researchers at Johns Hopkins University have developed an integrated genomic approach that potentially could help physicians predict which patients with non-small cell lung cancer will respond to therapy with immune checkpoint inhibitors.
Researchers at the University of Maryland School of Medicine developed a new nanoparticle drug formulation that targets a specific receptor on cancer cells and appears to be more effective than a standard nanoparticle therapy currently on the market to treat metastatic breast cancer.
In a phase III randomized clinical trial, patients with prostate cancer assigned to eat seven or more servings of vegetables and fruits daily saw no extra protection from the increased consumption of micronutrients.
Al B. Benson III was appointed deputy chair for policy and implementation by the ECOG-ACRIN Cancer Research Group.
Karen L. Reckamp was named director of the Division of Medical Oncology at Cedars-Sinai Cancer. Reckamp, a lung cancer expert, will serve as medical oncology director of the Women's Guild Lung Institute in Cedars-Sinai's Department of Medicine and associate director for clinical research at Cedars-Sinai Cancer.
Dolores Hambardzumyan was appointed senior faculty in the Department of Neurosurgery and a member of The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.
Douglas HanahanPing-Chih HoDouglas Hanahan was named a Distinguished Scholar at the Lausanne Branch of the Ludwig Institute for Cancer Research. A pioneering molecular biologist and renowned cancer researcher, Hanahan has made several seminal discoveries in cancer biology and immunology over the course of his career.
Northwell Health has acquired Queens Medical Associates, which is now part of the health system's cancer institute.
Richard Turman was named president on ACT for NIH, a Washington group that has played a key role in increasing federal appropriations for biomedical research over the past six years.
With a budgetary increase of $297 million in FY2020, NCI anticipates funding more than 125 additional competing awards over FY19 levels—and devoting more than $210 million in new funding to support extramural research and training opportunities.
